able cerebral
Able Cerebral is currently apply phase III clinical study with FDA for its controlled release of brain energy product. The product has shown remarkable therapeutic effectiveness for mid-stage and early stage Alzheimer's disease.
Able Cerebral is also developing a game changing, non-invasive medical device that will consolidate and recovery of brain memory for mid-stage and late stage Alzheimer's disease.
jun xia
Co-Founder / PresidentConsulate General of Canada in Shanghai
Lulu Mi
Life Sciences Trade CommissionerIHM-GBA
Based in Guanghzou, China, IHM-GBA is an innovation center focusing on high performance medical device. We are seeking global opportunities of bringing disruptive technologies to the Chinese market. We invest in and partner with startups that are interested in exploring China and use our resources to commercialize their products.